top of page
A World First: Automated Local Literature Monitoring for Pharmacovigilance – Download our White Paper Today!

3
Search


AI Risk Management: Approaches and Benefits
Risk management is one of the most valuable quality processes to ensure the continuous improvement of the biologit platform.

Jack Sullivan
Oct 3, 20234 min read


Feature Spotlight: Duplicate Detection in biologit MLM-AI Platform
In this article, we delve into the impact of duplicates in literature searches and introduce the automatic duplicate detection in Biologit M

Bruno Ohana
Jun 7, 20233 min read


Feature Spotlight: Teams Work Together in biologit MLM-AI
biologit MLM-AI is a literature monitoring platform that makes it easy for safety surveillance teams of all sizes to work together and...

Bruno Ohana
Apr 10, 20233 min read


"Nocebo Effect" and Biosimilars
by Natasha Troy Recently I read a report on the clinical effectiveness of an Infliximab biosimilar used as a switch from Remicade...

Natasha Troy
Nov 10, 20225 min read


Pharmacovigilance Case Studies from the Scientific Literature
At this year's World Drug Safety Conferences in Amsterdam and Boston, biologit presented two case studies detecting relevant safety events f
Nicole Baker
Oct 11, 20222 min read


Applying Good Machine Learning Practices (GMLP) at biologit
In October 2021 the U.S. Food and Drug Administration in conjunction with Health Canada and the MHRA (UK) released guiding principles on...

Jack Sullivan
Sep 21, 20228 min read


The use of AI in Biomedical Literature to Identify Antimicrobial Resistance
by Natasha Troy Antimicrobial Resistance: Case study from the scientific literature Antibiotic resistance is ,an inevitable biological...
Nicole Baker
Aug 31, 20229 min read


GVP-VI Guidelines and biologit MLM-AI
Naveen Basar and Bruno Ohana. The Guidelines on good pharmacovigilance practices - module VI is a document issued by the European...

Bruno Ohana
Aug 25, 20227 min read


Delivering AI in Pharmacovigilance: a Survey of Existing Guidance
There is continued interest from pharmaceutical companies, solution providers, and academia in improving pharmacovigilance processes with...

Bruno Ohana
Jul 4, 20228 min read
bottom of page
